RenovoRx

RNXTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$53.930 M

$1.20 -8.78%

Close of 6 Nov 2026

As of 6 Nov 2026, RenovoRx (RNXT) has a market capitalization of $53.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.12M

#3450 by revenue

Earnings

-$11.2M

Loss-making

Shares outstanding

48,250,592

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#328RafaelRFL$55.3M
#329Corbus PharmaceuticalsCRBP$54.8M
#330RenovoRxRNXT$53.9M
#331Rein TherapeuticsRNTX$53.6M
#332Verrica PharmaceuticalsVRCA$53.4M

What if RenovoRx were worth as much as…

Open the what-if tool →

Gold $28.2T

$625,685.39

Per share 523,586× higher

Bitcoin $1.53T

$33,854.75

Per share 28,330× higher

Apple $5.02T

$111,141.97

Per share 93,006× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for RenovoRx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.